{"id":"NCT00073307","sponsor":"Bayer","briefTitle":"Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer","officialTitle":"A Phase III Randomized Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-11","primaryCompletion":"2006-09","completion":"2010-04","firstPosted":"2003-11-21","resultsPosted":"2011-12-14","lastUpdate":"2014-02-06"},"enrollment":903,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Renal Cell"],"interventions":[{"type":"DRUG","name":"Sorafenib (Nexavar, BAY43-9006)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sorafenib (Nexavar, BAY43-9006)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate safety, efficacy (including quality of life), and pharmacokinetics of BAY43-9006 when added to Best Supportive Care in patients with unresectable and/or metastatic renal cell cancer, who have received one prior systemic regimen for advanced disease.","primaryOutcome":{"measure":"Final Overall Survival (OS) - Primary Analysis in the ITT (Intent To Treat) Population","timeFrame":"From start of randomization of the first subject (1Dec2003) until the data cut-off (8Sep2006) for the final OS analysis, approximately 33 months later","effectByArm":[{"arm":"Sorafenib (Nexavar, BAY43-9006)","deltaMin":542,"sd":null},{"arm":"Placebo","deltaMin":461,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.146"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":121,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","France","Germany","Hungary","Israel","Italy","Netherlands","Poland","Russia","South Africa","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["20085939","20399677","19850637","19757215","20651059","19451442","18840822","17551296","17215530","17189398","16965911","35484400","34775477"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":154,"n":451},"commonTop":["Diarrhea","Fatigue","Rash/Desquamation","Hand-Foot Skin Reaction","Alopecia"]}}